Typically, an institutional subscription works through IP verification, which eliminates the need to sign in with a username and password. Access is swift and unencumbered, and all we need is your IP address.
We will work with you to announce your free trial to your faculty and staff. At the end of your trial period, we provide you with the usage statistics. There is no obligation.
All institutional subscriptions are priced according to the size of the organization. You will be credited for any existing subscriptions within your institution. Contact Paul Goldberg, editor and publisher for more information.
The Cancer Letter has over 100 institutional subscribers in the U.S. and abroad. Here is a current list: